Status:

UNKNOWN

3D Printed Implants for the Defect Reconstruction in Patients With Chest Wall Tumors

Lead Sponsor:

Blokhin's Russian Cancer Research Center

Conditions:

Tumor of Bone

Chest Wall Tumor

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

A patient with a tumor lesion of the chest wall undergoes CT scan with a step width of less than 1 mm, then engineers design an individual model to replace the defect. Using a 3D printer, a model is m...

Detailed Description

A patient with a tumor lesion of the chest wall undergoes CT scan with a step width of less than 1 mm, then engineers design an individual model to replace the defect. Using a 3D printer, a model is m...

Eligibility Criteria

Inclusion Criteria:

  • Malignant neoplasm of ribs, sternum and clavicle
  • Malignant neoplasm of the connective and soft tissues of the chest
  • Neoplasm of uncertain or unknown nature of ribs, sternum and collarbone
  • Benign neoplasm of ribs, sternum and collarbone
  • Tumor lesions of the chest wall of any localization, malignant and benign, as well as of an uncertain or unknown nature
  • For malignant tumors: Grade 1-3
  • Lack of distant metastases
  • Signed informed consent

Exclusion Criteria:

  • Children, women during pregnancy, childbirth, women during breastfeeding.
  • Military personnel, with the exception of contract military personnel.
  • Persons with mental disorders.
  • Persons detained, taken into custody, serving a sentence in the form of restriction of freedom, arrest, imprisonment or administrative arrest.
  • Patients with distant metastases (except for a solitary focus in the chest wall without other manifestations of the disease)
  • Inoperable tumor
  • The presence of another malignant tumor at the time of examination
  • ECOG 4
  • Having an active or chronic fungal / bacterial / viral infection
  • Uncontrolled chronic diseases of the liver, kidneys in the acute stage
  • Presence of metastases

Key Trial Info

Start Date :

January 10 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT05057143

Start Date

January 10 2022

End Date

December 1 2025

Last Update

April 1 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Federal State Budgetary Institution "N.N. Blokhin National Medical Research Center of Oncology" оf the Ministry of Health of the Russian Federation

Moscow, Russia, 115478